Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $161,000 | -74.2% | 11,295 | -74.3% | 0.01% | -75.8% |
| Q2 2019 | $625,000 | -5.0% | 43,966 | 0.0% | 0.03% | -2.9% |
| Q1 2019 | $658,000 | +37.9% | 43,966 | +15.7% | 0.03% | +21.4% |
| Q4 2018 | $477,000 | -23.3% | 38,003 | +6.7% | 0.03% | +3.7% |
| Q3 2018 | $622,000 | +15.2% | 35,632 | +0.0% | 0.03% | +92.9% |
| Q2 2018 | $540,000 | +0.7% | 35,626 | +1.6% | 0.01% | 0.0% |
| Q1 2018 | $536,000 | +29.5% | 35,069 | +7.3% | 0.01% | +55.6% |
| Q4 2017 | $414,000 | +2.7% | 32,675 | +2.8% | 0.01% | 0.0% |
| Q3 2017 | $403,000 | +3.6% | 31,800 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $389,000 | -7.2% | 31,800 | 0.0% | 0.01% | -10.0% |
| Q1 2017 | $419,000 | +39.2% | 31,800 | +46.2% | 0.01% | +42.9% |
| Q4 2016 | $301,000 | – | 21,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
| Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
| MAI Capital Management | 19,087 | $264,362 | 0.00% |
| SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
| RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
| First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
| Operose Advisors LLC | 90 | $1,247 | 0.00% |
| Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |